5th Interdisciplinary Pain and Opioid Crisis Seminar

---

LIVE

Friday, April 21, 2023, 7:00 AM - Saturday, April 22, 2023, 2:00 PM, MD Anderson - Virtual


AMA PRA Category 1 Credits™ (13.25 hours), ABA MOCA Part 2 (13.25 hours), ABIM MOC Part 2 (13.25 hours), ANCC - Nursing Contact Hour(s) (13.25 hours), Controlled Substances (13.25 hours), Medical Ethics/Professional Responsibility (13.25 hours), Non-Physician Attendance (13.25 hours), Pain and Opioid (13.25 hours), Pharmacotherapeutics (13.25 hours)

**DEA REQUIREMENT - THIS ACTIVITY ALSO MEETS THE NEW ONE-TIME, EIGHT-HOUR TRAINING REQUIREMENT FOR ALL
DRUG ENFORCEMENT ADMINISTRATIN (DEA) - REGISTERED PRACTITIONERS ON THE TREATMENT AND MANAGEMENT
OF PATIENTS WITH AN OPIOID OR OTHER SUBSTANCE ABUSE DISORDER**

This activity will offer safe and appropriate use of opioids for cancer pain, which is of utmost importance in view of the national opioid crisis. Clinicians are required to act as gatekeepers by mitigating the potential harms associated with inappropriate opioid use while ensuring their rational and effective use in the treatment of cancer pain. This is possible when they utilize opportunities to enhance their knowledge and competencies in the use of opioids. The 5th Pain and Opioid Crisis Seminar seeks to provide healthcare providers the unique opportunity to achieve such competencies in their careers. It will offer cutting-edge lectures and interactive panel discussions from world expert faculty with diverse clinical and research backgrounds in pain and opioids. This exciting educational event will provide practical evidence-based guidance and solutions to address clinical, public health, and legal issues related to the use and nonmedical use of opioids. Attendees will obtain up-to-date information and acquire high-quality knowledge while earning valuable CME and NCPD credits as well as Maintenance of Certification (MOC) points from the American Board of Internal Medicine (ABIM) and American Board of Anesthesiology (ABA).

1. Apply the basic principles of pain management and chronic opioid therapy;
2. Implement ways to improve patient care and ensure patient/family safety related to the use of opioids.
3. Utilize practical strategies to manage patients with co-occurring cancer pain and nonmedical opioid use;
4. Apply non-pharmacologic approaches to manage pain in patients with opioid use disorder.

Virtual registration for the 5th Interdisciplinary Pain and Opioid Seminar, will open at 7:30 am on Friday, April 21, 2023, and the seminar will begin at 8:00 am. The conference will adjourn at 1:20 pm on Saturday, April 22, 2023. Advanced registration is encouraged. Please see registration form for applicable fees.

Advanced registration is encouraged. The deadline for advanced registration is April 14, 2023.

Fees:

Registration Category	BEFORE Apr. 14	AFTER Apr. 14
MD Anderson Physicians/Scientists (MD, PhD)	$180	$200
MD Anderson Trainees and Allied Health Professions	$60	$75
MD Anderson Pharmacist, Nurses, APPs	$125	$140
Non-MDA Physicians/Scientists (MD, PhD)	$250	$275
Non-MDA Pharmacist, Nurses, APPs	$150	$175
Non-MDA Trainees and Allied Health Professions	$80	$95

We accept the following forms of payment:
  •Credit Cards (MasterCard, VISA, and American Express)
  •Check (Payable to The University of Texas MD Anderson Cancer Center; through U.S. banks only)

Mail checks to:
   Continuing Professional Education (CPE) – Unit 1781
   The University of Texas MD Anderson Cancer Center
   P.O. Box 301407
   Houston, Texas 77230-1407

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on your profile during the process. 

Telephone registrations are not accepted.

Refund/Cancellation Policy
The registration fee, minus a $35 administrative handling fee, is refundable if a written request is received on or before April 14, 2023.  No refunds will be granted after this date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. 

The Department of Continuing Professional Education (CPE), reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of the CPE is limited to the registration fee. CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in an activity and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Special Assistance
For additional information or Special Assistance, contact CPE at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected]

Evaluation
A course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. The survey link will be provided during the course.

 

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

 The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credits™. 

The University of Texas MD Anderson Cancer Center designates this live activity will award 13.50 Nursing contact hours.

The training also qualifies for 5 hours of Risk Management Education (RME).

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.